Table 4.
Quality assessment
|
In vitro studies |
In vivo studies |
Clinical studies |
||||||
|---|---|---|---|---|---|---|---|---|
| citation | quality score | method score | citation | quality score | method score | citation | quality score | method score |
| Modak, 1992 | 14/19 | A | Avramovic, 1991 | 19/23 | C | Maki, 1997 | 11/14 | C |
| Bergamini, 1996 | 16/19 | B | Sardelic, 1995 | 18/23 | A | Raad, 1997 | 14/14 | B |
| Garrison, 1997 | 14/19 | A | Garrison, 1997 | 21/23 | A | Darouiche, 1999 | 11/14 | B |
| Sampath, 2001 | 14/19 | B | Bandyk, 2001 | 10/12 | D | |||
| Norton, 2001 | 13/19 | C | Wright, 2001 | 8/12 | B | |||
| Tambe, 2001 | 15/19 | B | Chatzinikolaou, 2003 | 11/12 | A | |||
| Martro, 2003 | 16/19 | B | Chatzinikolaou, 2003 | 13/14 | B | |||
| Aarestrup, 2004 | 18/19 | A | Hanna, 2004 | 12/14 | B | |||
| Munson, 2004 | 16/19 | A | Schuerer, 2007 | 9/12 | D | |||
| Bayston, 2009 | 17/19 | A | Timsit, 2009 | 9/14 | B | |||
| Skovgaard, 2013 | 16/19 | A | Batra, 2010 | 8/12 | A | |||
| Johnson, 2013 | 14/19 | B | Lee, 2011 | 11/13 | B | |||
| Apisarntharak, 2014 | 11/19 | B | Ramos, 2011 | 10/12 | A | |||
| Suwantarat, 2014 | 18/19 | A | Ho, 2012 | 12/13 | B | |||
| Wesgate, 2016 | 15/19 | A | Soma, 2012 | 8/12 | A | |||
| Ekizoglu, 2016 | 16/19 | B | Schlett, 2014 | 10/14 | A | |||
| Berard, 2019 | 16/19 | A | Mendoza-Olazaran, 2014 | 10/12 | A | |||
| Rosenblatt, 2019 | 13/19 | A | Chung, 2015 | 8/12 | B | |||
| McNeil, 2016 | 8/12 | B | ||||||
| Gilbert, 2016 | 12/14 | C | ||||||
| Lowe,2017 | 9/12 | B | ||||||
| Turnbull, 2018 | 6/12 | D | ||||||
| Velazquez-Meza, 2017 | 8/12 | B | ||||||
| Choudhury, 2017 | 8/12 | C | ||||||